Search research articles
Contact Us
Filters
Showing results (31-40 of 33) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 33 results.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
July 25, 2022
Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial
Tarek Hassanein, Dean Tai, Chenghai Liu, et al.
Antimicrobial Agents and Chemotherapy
|
August 10, 2016
Preclinical Profile and Clinical Efficacy of a Novel Hepatitis C Virus NS5A Inhibitor, EDP-239
Christopher M Owens, Bradley B Brasher, Alex Polemeropoulos, et al.
The New England Journal of Medicine
|
May 6, 2014
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV
Peter Ferenci, David Bernstein, Jacob Lalezari, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 33) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 33 results.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
July 25, 2022
Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial
Tarek Hassanein, Dean Tai, Chenghai Liu, et al.
Antimicrobial Agents and Chemotherapy
|
August 10, 2016
Preclinical Profile and Clinical Efficacy of a Novel Hepatitis C Virus NS5A Inhibitor, EDP-239
Christopher M Owens, Bradley B Brasher, Alex Polemeropoulos, et al.
The New England Journal of Medicine
|
May 6, 2014
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV
Peter Ferenci, David Bernstein, Jacob Lalezari, et al.
Page
of 4